Article Text

Download PDFPDF
A surgeon’s trial success of curing pedal eumycetoma
  1. Baseem Choudhry1,
  2. James Mitchell2 and
  3. Steve Milner1
  1. 1Royal Derby Hospital, Derby, UK
  2. 2King's Mill Hospital, Sutton-in-Ashfield, UK
  1. Correspondence to Baseem Choudhrybaseem.choudhry{at}nhs.net

Abstract

Mycetoma is a chronic infection of underlying fungal (eumycetoma) or bacterial (actinomycetoma) origin. It is characterised by a clinical triad of tumour-like swelling, actively draining sinuses and macroscopic grains of characteristic colours.

We the case of a 66-year-old woman on immunosuppressive therapy presenting with eumycetoma of the foot (Madura foot). The fungal organism cultured was Acrophialophora fusispora.

This case was managed with a combination of extensive surgical debridement, and packing with calcium sulfate (Stimulan) beads impregnated with vancomycin and voriconazole. As far as the authors are aware, this is a novel adjunct to the surgical treatment of deep fungal infection in the foot.

Eumycetoma treated with surgery and oral antifungal therapy leads to cure rates of 25%–35%. This novel treatment seems to bear further investigation for the potential to improve cure rates. At 8 months follow-up, our patient appears to be making good progress with no current signs of recurrence.

  • Drugs and medicines
  • Orthopaedics
  • Migration and health

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Contributors JM substantially contributed to data acquisition, literature review and drafting article. BC substantially contributed to interpretation of data, literature review and critical revision for relevant intellectual content. SM substantially contributed to conception of work, critical revision of draft paper and final approval of the version to be published. All authors agreed to be accountable to work published as accurate to best of their knowledge.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.